# UNC Oncology K12

> **NIH NIH K12** · UNIV OF NORTH CAROLINA CHAPEL HILL · 2024 · $756,019

## Abstract

ABSTRACT
This is a competing renewal of the University of North Carolina at Chapel Hill (UNC) Oncology K12. The UNC
K12 continues to meet an unmet need at UNC by providing a cancer-specific training and mentoring program
for junior faculty in multiple departments and divisions within the UNC School of Medicine. These departments
and divisions include: Divisions of Adult Oncology, Hematology, and Surgical Oncology, Division of Pediatric
Hematology/Oncology, as well as the Departments of Radiation Oncology, Pathology and Lab Medicine, and
Urology. The UNC K12 is the only cancer-specific junior faculty training program at the University. The
primary goal of the UNC K12 is to develop a successful, rigorously trained cadre of researchers focused on
patient-oriented research in three main focus areas including translational research, clinical trials research, and
health services research. The UNC K12 offers several unique aspects of training and mentoring including
vertical integration with other translational training grants (allowing for mentoring opportunities), communication
and skills development (both scientific and lay), and didactic and experiential training on translational or
patient-oriented research. The program will continue to be led by Dr. William Kim, Professor of Medicine,
Genetics, and Pharmacology. He will be assisted by Associate Director (AD), Dr. Lisa Carey and Assistant
Director (aD), Dr. Katie Reeder-Hayes who bring expertise in clinical trials and outcomes research respectively.
The Internal Advisory Board (IAB) and External Advisory Board (EAB) members have been invaluable in
guiding the UNC K12 over the past funding period and will continue to provide significant additional experience
and expertise in the development, administration, and evaluation of junior faculty training programs. The UNC
K12 will admit 2 junior faculty scholars per cohort year, for a total of 4 scholars at a time. Each scholar will
receive 2 years of support. During the last funding period we were able to fund 12 scholars (16% of which were
URI in medicine) whose records and accomplishments are detailed in the progress report but include the
promotion of scholars to Associate Professor, high impact publications, as well as several NCI K08 awards and
other significant funding. Major changes from our last renewal include the recruitment of Dr. Carey and Dr.
Reeder-Hayes as AD and aD respectively, the addition of Dr. Sandra Wong to the EAB to give guidance on
unique challenges faced by surgeon-scientists as well as health services research, and finally, the pairing of a
patient advocate with each scholar (PAP Program) to enhance the scholar's ability to communicate with non-
scientific audiences as well as to give input into research projects. The UNC K12 has a track record of
success, serves an unmet need for cancer-specific training, and will continue to serve as a nexus for the
development of patient-oriented junior faculty researchers at UNC.

## Key facts

- **NIH application ID:** 10878260
- **Project number:** 2K12CA120780-16
- **Recipient organization:** UNIV OF NORTH CAROLINA CHAPEL HILL
- **Principal Investigator:** WILLIAM Y. KIM
- **Activity code:** K12 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $756,019
- **Award type:** 2
- **Project period:** 2007-09-17 → 2029-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10878260

## Citation

> US National Institutes of Health, RePORTER application 10878260, UNC Oncology K12 (2K12CA120780-16). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10878260. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*